4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-129263
Chief Accounting Officer sold 554 shares at $0.55 ($304)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-19 | Sale : show line 1 in the form | −554 | $0.55 | $304 | 68,506 | D |
| Open-market sales · 554 sh · avg $0.55 · $304 | ||||||
Loading xslF345X05/ownership.xml…